Pieris Pharmaceuticals Inc (PIRS): PIRS bullish 3.41 gap up on developme...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Friday, 05/05/2017 4:00:34 PM

Friday, May 05, 2017 4:00:34 PM

PIRS bullish 3.41

gap up on development deal with AstraZeneca

http://ir.pieris.com/press-releases

normal chart

log chart

Keep Last Read

Next 10 Prev Next

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:37:34 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:12:19 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:19:42 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 02:59:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:30:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:02 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/31/2023 08:15:35 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/10/2023 09:04:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:24:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 01:15:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 11:30:36 AM

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Only $200 per official company press release!